Androstanes
US4197296A · kind A · utility
6Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 1978 |
| Grant date | Apr 8, 1980 |
| Priority date | — |
| Expiry date | Sep 26, 1998 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/001
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Steroids of the androstane series are described which possess a 3.alpha.-hydroxy group, a 5.alpha.- or 5.beta.- hydrogen atom, a 10- methyl group, an 11.alpha.- substituted amino group. The 17-position may be unsubstituted or substituted by a methyl or ethyl group in the .beta.-configuration or by an oxo group, or there may be a 16.beta., 17.beta.-epoxide group. A 2.beta.-alkoxy group may optionally be present. The compounds, particularly their salts, have anaesthetic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.